An integrated pre-filled polymer syringe with an oxygen scavenger prevents aggregation and precipitation of concentrated immunoglobulin solutions.
Styrene-isoprene-styrene block copolymer adhesive matrix enhances donepezil skin penetration rate.
Antibodies bind human leptin receptors to activate signaling, bypassing resistance mechanisms that limit supplemental leptin efficacy.
An alpha-aminoamide derivative reversibly inhibits monoamine oxidase B through non-covalent bonding interactions.
An enzymatic process purifies PHB-co-HV to yield high-purity (R)-3-hydroxybutyrate and (R)-3-hydroxyvalerate mixtures.
Combining glutamate modulators with antioxidant gene delivery addresses astrocytic dysfunction and motor neuron degeneration in ALS.
Opposite cell differentiation program uses phenotypically stable donor cells to regenerate damaged tissues and restore organ functionality.
Cyclic cyanoenone derivatives activate NRF2 to treat neurodegenerative diseases while maintaining safety profiles.
Non-ionic surfactant micelles dissolve cannabinoids in aqueous solvent, increasing bioavailability seven-fold while eliminating gastrointestinal side effects.
Implantable pump transports cerebrospinal fluid to a separation device using dialysis membranes and electrostatic filters.
Selective M1/M4 agonists minimize peripheral cholinergic side effects while treating cognitive disorders.
Alpha-sheet polypeptide multimers covalently link monomers to neutralize toxic oligomers and prevent amyloid fibril formation.
Measuring SYNCRIP expression normalizes miR-137 activity to reduce withdrawal symptoms, addressing the lack of effective treatments with unclear mechanisms.
Bacillus coagulans Unique IS-2 formulation modulates gut microbiome composition to alleviate depressive symptoms.
Dianhydrogalactitol crosses the blood-brain barrier and resists MGMT inactivation to treat refractory glioblastoma.
Water-soluble turmeric extract resists amyloid β-induced microglia activation, lowering PGE2, TNF-α, and IL-1β levels to treat Alzheimer's disease.
GAT-3 inhibitors reduce excessive hippocampal GABA levels, rescuing long-term potentiation and reversing memory loss progression in Alzheimer's disease.
Deutero- and fluoro-derivatives of Ibogaine address the lack of novel compounds by enhancing therapeutic benefits through structural parameter changes.
Timed-release donepezil composition aligns plasma concentration with circadian rhythm, reducing sleep disturbances and gastrointestinal side effects.
Hydroxyl-free polymer matrix prevents rivastigmine decomposition without antioxidants, maintaining stability under varying humidity and temperature.
Stress-induced isolation of pluripotent adipose stem cells enables efficient tissue regeneration while preventing teratoma formation and immunorejection.
κ-CPTx-bt101 inhibits potassium currents with high specificity, reducing toxic side effects common in traditional chemical drugs.
Administering AMPA and NMDA receptor antagonists stops seizures caused by nerve agents.
Unsupervised clustering isolates rare genetic variants from heterogeneous populations, enabling precise diagnostic identification of autoimmune disorders.